FDA Drug Recalls

Recalls / Class II

Class IID-0232-2026

Product

Benco dental Graham CHEMICAL CO., Mepivacaine HCI 3% (30 mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Distributed by Benco Dental 295 Center Point Blvd, Pittston, PA 18640, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66975-406-51.

Brand name
Mepivacaine
Generic name
Mepivacaine Hydrochloride
Active ingredient
Mepivacaine Hydrochloride
Route
Submucosal
NDC
66975-406
FDA application
ANDA088387
Affected lot / code info
Lot: D05159H, expires: 07-31-2027

Why it was recalled

Defective container: cracked/broken cartridges

Recalling firm

Firm
Novocol Pharmaceutical of Canada, Inc.
Manufacturer
Benco Dental
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
25 Wolseley Crt, Cambridge, N/A, Canada

Distribution

Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2025-10-31
FDA classified
2025-12-12
Posted by FDA
2025-12-24
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0232-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.